Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Miguel Santin
The treatment of co-infected patients with normal ALT would be very important because the evolution of cirrhosis in this patients is quicker and frequently than mono-infected patients.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients over 18 years old
Hepatitis C co infected with stable HIV-1 and normal ALT (CASE) or elevated levels of ALT (CONTROL)
CD4 \> 200 cel/mL
Stable anti-retroviral treatment for HIV during at least, the 6 previous months to the inclusion
Negative contraception test
Informed consent signed
You may not be if
Pregnancy
Any previous treatment for CHC
Any experimental treatment in the 6 previous weeks to the inclusion
Cirrhosis grade B or C (Child-Pugh)
Treatment with colony-stimulating factors, didanosine or zidovudine, immunomodulator therapy, isoniazid, rifampicin, …
